Paid Clinical Trials in Mesa, AZ
As of July 2026, 61 paid clinical trials are recruiting in Mesa, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Mesa offers studies at sites including Banner Children's at Desert for conditions such as Arthritis, Psoriatic, Heart Failure, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Mesa
Trials by drug in Mesa
Filter results
Newly added in Mesa
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
58 clinical trials
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Assessment of CCM in HF With Higher Ejection Fraction
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
CCM OPEN HF Registry
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Top Research Study Locations in Mesa
Researchers run research studies in Mesa, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Banner Children's at Desert | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 17 |
| Ironwood Cancer & Research Centers | Advanced Non-Small Cell Lung Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| Arizona Arthritis & Rheumatology Associates (AARA) - Mesa | Gout, Tophaceous Gout | 2 |
| Arizona Arthritis & Rheumatology Associates (AARA), P.C. - Mesa | Acute Gout Flare, Arthritis, Gout | 2 |
| Barnet Dulaney Perkins Eye Center | Neovascular Age-related Macular Degeneration, Open-Angle Glaucoma | 2 |
| Del Sol Research Management - Mesa | Irritable Bowel Syndrome, Constipation, Diarrhea | 2 |
| GSK Investigational Site | Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease, Systemic Lupus Erythematosus | 2 |
| Barnet Dulaney Perkins Eye Centers | Open Angle Glaucoma (OAG), Neovascular Age-related Macular Degeneration | 2 |
| CardioVascular Associates of Mesa | Diastolic Heart Failure, Heart Failure, Heart Failure With Mid Range Ejection Fraction | 2 |
| Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers | Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC) | 1 |
| AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Mesa | Overweight or Obesity, Psoriatic Arthritis | 1 |
| AARA Clinical Research 1 | Arthritis, Psoriatic | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ | Psoriatic Arthritis | 1 |
| Arizona Arthritis and Rheumatology Research PLLC | Diffuse Cutaneous Systemic Sclerosis | 1 |
| Banner Medical Center | Bradycardia, Heart Failure, Ventricular Dysfunction | 1 |
| Banner Surgery Center - Desert | Lumbar Spinal Stenosis | 1 |
| Banner Surgery Center - Mesa | Lumbar Spinal Stenosis | 1 |
| Barnet Dulaney Perkins Eye Center (01018) | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Canyon Surgl Ctr | Lumbar Spinal Stenosis | 1 |
| Care Access - 801 South Power Road, Mesa | Osteoarthritis, Overweight or Obesity | 1 |
| Chan Heart Rhythm Institute | Diastolic Heart Failure, Heart Failure, Heart Failure With Mid Range Ejection Fraction | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Del Sol Research Management, LLC - Mesa | Asthma | 1 |
| Desert Clinical Research | T2DM, Type 2 Diabetes Mellitus | 1 |
Active & Upcoming Studies in Mesa (2026)
Recruiting trials in Mesa grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (17 active studies)
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
- This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. · Phase 3 · Pfizer
Eye & vision (6 active studies)
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
- Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) · Phase 3 · AbbVie
Diabetes & metabolic (5 active studies)
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus · Phase 2 · Hanmi Pharmaceutical Company Limited
Cardiovascular (4 active studies)
- CCM OPEN HF Registry · Impulse Dynamics
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Neurology & pain (1 active study)
- Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare · Phase 2, Phase 3 · Olatec Therapeutics, Inc.
Common conditions studied in Mesa
- Arthritis, Psoriatic (3 active studies)
- Heart Failure (3 active studies)
- Acute Myeloid Leukemia (2 active studies)
- B Acute Lymphoblastic Leukemia (2 active studies)
- Gout (2 active studies)
- Irritable Bowel Syndrome (2 active studies)
Leading research sponsors in Mesa
- Children's Oncology Group
- National Cancer Institute (NCI)
- Pfizer
- Eli Lilly and Company
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Mesa?
There are approximately 61 recruiting clinical trials in Mesa, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Mesa pay participants?
Most recruiting trials in Mesa compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Mesa?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Mesa?
The most common conditions under active study in Mesa include Arthritis, Psoriatic (3), Heart Failure (3), Acute Myeloid Leukemia (2), B Acute Lymphoblastic Leukemia (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Mesa?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Mesa on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Mesa?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Mesa?
Recruiting research sites in Mesa include Banner Children's at Desert, Ironwood Cancer & Research Centers, Arizona Arthritis & Rheumatology Associates (AARA) - Mesa, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Mesa right now?
The largest active categories in Mesa are Cancer & tumors (17), Eye & vision (6), Diabetes & metabolic (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.